FDA creates pediatric review agency

Share this article:
FDA commissioner Andrew von Eschenbach has approved creation of an agency Pediatric Review Committee (PeRC) to provide consultation on and general review of pediatric information submitted to the FDA in pediatric plans, assessments, and studies conducted by sponsors and applicants.

A memo by deputy commissioner Janet Woodcock said PeRC will among other items: review all written requests before issuance; may review studies submitted in response to a written request to make a recommendation on exclusivity determinations; will provide consultation to reviewing divisions on all pediatric plans and assessments prior to approval of an application or supplement for which a pediatric assessment is required; and will provide review of all deferrals and waivers from the requirement to submit assessments.

Woodcock said PeRC will conduct a retrospective review and analysis of a representative sample of assessments submitted and deferrals and waivers.

Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Antidote: On Cystic Fibrosis treatments

Antidote: On Cystic Fibrosis treatments

Recent treatments in CF, including the inhaled antibiotic Tobramycin, have increased lifespan well into adulthood.

The $3 generic and the $1,000 pill: pharma outsiders just don't get it

The $3 generic and the $1,000 pill: pharma ...

What do you call the people who treat medical breakthroughs as if they were bank heists? Malicious? Uninformed? Not with it?

Leadership Exchange Uncut : The Agency-Client Relationship

Leadership Exchange Uncut : The Agency-Client Relationship

Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"